RCUS announcements Arcus Biosciences, Inc. announcements and dividends declared NYSE
Arcus Biosciences, Inc. Complete list of announcements declared & dividend announcements by Arcus Biosciences, Inc. RCUS
Arcus Biosciences, Inc. RCUS listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Arcus Biosciences, Inc. RCUS
B of A Securities Maintains Arcus Biosciences (RCUS) Neutral Recommendation
Fintel reports that on September 5, 2023, B of A Securities maintained coverage of Arcus Biosciences (NYSE:RCUS) with a Neutral recommendation.
Announcement as on 06 September 2023
Arcus Biosciences, Gilead shares are down after sharing data about new lung cancer drug
Shares of Arcus Biosciences Inc. were down 17.2% in premarket trading on Tuesday, the day after the company said the experimental treatment for metastatic non-small cell lung cancer that it's developing with Gilead Sciences Inc. improved progression-free
Announcement as on 20 December 2022
Arcus Biosciences shares rocket premarket after Gilead exercises options for 3 cancer programs for 5 million
Shares of Arcus Biosciences Inc. rocketed 21% in premarket trading Thursday, after Gilead Sciences Inc. said it's exercising options to three programs in the company's clinical-stage portfolio for payments of 5 million. The programs in question includ
Announcement as on 18 November 2021
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
Arcus Biosciences, Inc. (RCUS) came out with a quarterly loss of .11 per share versus the Zacks Consensus Estimate of a loss of .13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 08 November 2021
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
Arcus Biosciences, Inc. (RCUS) came out with a quarterly loss of .11 per share versus the Zacks Consensus Estimate of a loss of .13. This compares to earnings of [CO].03 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 08 November 2021
Announcements by Arcus Biosciences, Inc. first page | Next page |
RCUS Arcus Biosciences, Inc. current price & indicator signals
Recent prices of RCUS Arcus Biosciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
26 Tue Nov 2024 | 15.79 | 14.36 to 16.60 | 0% | 1.61 times |
26 Tue Nov 2024 | 15.79 | 14.36 to 16.60 | 8.45% | 1.61 times |
25 Mon Nov 2024 | 14.56 | 14.55 to 15.40 | -0.95% | 1.21 times |
22 Fri Nov 2024 | 14.70 | 14.20 to 15.07 | 2.94% | 0.8 times |
21 Thu Nov 2024 | 14.28 | 14.15 to 14.71 | -2.33% | 1.01 times |
20 Wed Nov 2024 | 14.62 | 14.26 to 15.01 | 0.76% | 0.89 times |
19 Tue Nov 2024 | 14.51 | 14.19 to 14.77 | 0.55% | 0.53 times |
18 Mon Nov 2024 | 14.43 | 14.35 to 15.73 | -8.09% | 1.02 times |
15 Fri Nov 2024 | 15.70 | 14.90 to 16.05 | -0.44% | 1.38 times |
14 Thu Nov 2024 | 15.77 | 15.67 to 16.48 | -4.02% | 0.71 times |
13 Wed Nov 2024 | 16.43 | 16.30 to 17.21 | -2.03% | 0.84 times |
12 Tue Nov 2024 | 16.77 | 16.74 to 17.76 | -5.52% | 0.66 times |
Videos related to: RCUS announcements Arcus Biosciences, Inc. announcements and dividends declared NYSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance